Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose atorvastatin in STEMI patients undergoing primary PCI
ChiCTR-TRC-13003747Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in myocardial infarction (MI) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Major adverse cardiovascular events within 30 days after randomization. Started Apr 2013; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-TRC-13003747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003747.